Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Schwenk ES, Ferd P, Torjman MC, Li CJ, Charlton AR, Yan VZ, McCurdy MA, Kepler CK, Schroeder GD, Fleischman AN, Issa T. Intravenous versus oral acetaminophen for pain and quality of recovery after ambulatory spine surgery: a randomized controlled trial. Reg Anesth Pain Med. 2025 06 10; 50(6):483-488.
-
Ibrahim A, Shalabi L, Zreigh S, Ramadan S, Mourad S, Eljadid G, Beshr M, Abdelaziz A, Elhadi M, Sabouret P, Mamas M. Comparative Efficacy and Safety of Low-Dose Direct Oral Anticoagulants Versus Dual Antiplatelet Therapy Following Left Atrial Appendage Occlusion in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis. Catheter Cardiovasc Interv. 2025 05; 105(6):1311-1319.
-
Ottone OK, Mundo JJ, Kwakye BN, Slaweski A, Collins JA, Wu Q, Connelly MA, Niaziorimi F, van de Wetering K, Risbud MV. Oral Citrate Supplementation Mitigates Age-Associated Pathologic Intervertebral Disc Calcification in LG/J Mice. Aging Cell. 2025 May; 24(5):e14504.
-
Schilder RJ, Rasco D, Sharma MR. An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors. Neoplasia. 2025 03; 61:101133.
-
Derman RJ, Bellad MB, Somannavar MS, Bhandari S, Mehta S, Mehta S, Sharma DK, Yogeshkumar S, Charantimath U, Patil AP, Mallapur AA, Ramadurg U, Sangavi R, Patil PS, Roy S, Vastrad P, Shekhar C, Leiby BE, Hartman RL, Georgieff M, Mennemeyer S, Aghai Z, Thind S, Boelig RC. Single-dose intravenous iron vs oral iron for treatment of maternal iron deficiency anemia: a randomized clinical trial. Am J Obstet Gynecol. 2025 Aug; 233(2):120.e1-120.e18.
-
Lam K, Mondick JT, Peltz G, Wu M, Kraft WK. Bayesian Population Pharmacokinetic Modeling of Ondansetron for Neonatal Opioid Withdrawal Syndrome. Clin Transl Sci. 2025 Feb; 18(2):e70147.
-
Ye Q, Shvartsbart A, Li Z, Gan P, Policarpo RL, Qi C, Roach JJ, Zhu W, McCammant MS, Hu B, Li G, Yin H, Carlsen P, Hoang G, Zhao L, Susick R, Zhang F, Lai CT, Allali Hassani A, Epling LB, Gallion A, Kurzeja-Lipinski K, Gallagher K, Roman V, Farren MR, Kong W, Deller MC, Zhang G, Covington M, Diamond S, Kim S, Yao W, Sokolsky A, Wang X. Discovery of INCB159020, an Orally Bioavailable KRAS G12D Inhibitor. J Med Chem. 2025 Jan 23; 68(2):1924-1939.
-
Cowan E, O'Brien-Lambert C, Eiting E, Bull E, Ryder J, Calderon Y, Salsitz E. Emergency department-initiated oral naltrexone for patients with moderate to severe alcohol use disorder: A pilot feasibility study. Acad Emerg Med. 2025 05; 32(5):488-497.
-
Mandloi S, Nunes K, Sina EM, Benedict PA, Kahn C, Duffy A, Shing SR, Urdang ZD, Rosen M, Toskala E, Rabinowitz MR, Nyquist GG. Epistaxis Risk in Patients Treated With Left Atrial Appendage Occlusion Versus Oral Anticoagulation. Laryngoscope. 2025 May; 135(5):1636-1641.
-
Prescott CR, Cohen EJ, Hochman JS, Troxel AB, Lu Y, Twi-Yeboah A, Jimenez CL, Mian SI, Mazen CY, Warner DB, Baratz KH, Jeng BH. Baseline Participant Characteristics at Enrollment in the Zoster Eye Disease Study. Cornea. 2024 Dec 01; 43(12):1473-1480.